Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $14.8900 (-1%) ($14.6500 - $14.9900) on Wed. May. 29, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.04% (three month average) | RSI | 24 | Latest Price | $14.8900(-1%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO declines -0.9% a day on average for past five trading days. | Weekly Trend | HALO declines -2.8% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(54%) IWO(54%) IWM(50%) XBI(49%) ARKG(48%) | Factors Impacting HALO price | HALO will decline at least -1.02% in a week (0% probabilities). VXX(-20%) UUP(-6%) VIXM(-4%) TLT(-4%) IGOV(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.02% (StdDev 2.04%) | Hourly BBV | 0 () | Intraday Trend | -0.3% | | | |
|
1 - 5 Day Possible Target | $7.32(-50.84%) | Resistance Level | $15.91 | 5 Day Moving Average | $15.23(-2.23%) | 10 Day Moving Average | $15.41(-3.37%) | 20 Day Moving Average | $15.91(-6.41%) | To recent high | -15.3% | To recent low | 0% | Market Cap | $2.035b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |